CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...